At Personalis, we are transforming the active management of cancer through more personalized testing. Our assays combine tumor-and-normal profiling with proprietary algorithms to deliver the most advanced insights, even as cancer evolves over time. With our industry-leading products, you can detect recurrence at the earliest timepoints, confidently select therapies based on ultra-comprehensive genomic profiling, and enhance your biomarker strategy for drug development.